---
figid: PMC3252833__cdd2011121f3
figlink: /pmc/articles/PMC3252833/figure/fig3/
number: Figure 3
caption: Sensitisation of type 2 cancer cells towards DR-induced killing by synthetic
  IAP antagonists. (a) This image represents a type-2 cancer cell that, through overexpression
  of anti-apoptotic Bcl-2 proteins (e.g. Bcl-2 or Mcl-1) and/or XIAP, has become highly
  resistant towards FasL- or TRAIL-induced apoptosis. (b) Addition of an IAP-antagonistic
  small molecular Smac-mimetic, ideally an XIAP-selective inhibitor to minimise side
  effects, uncouples the DR-induced apoptotic pathway from its mandatory crosstalk
  to the mitochondrial apoptotic pathway, thereby sensitising the cancer cells towards
  FasL-, TRAIL- or TNF-induced killing. Combination therapy with additional standard
  chemotherapeutic drugs, or direct targeting of anti-apoptotic Bcl-2 proteins by
  BH3 mimetics, thereby triggering MOMP, might further sensitise the cancer cell to
  undergo apoptosis
pmcid: PMC3252833
papertitle: 'Fas death receptor signalling: roles of Bid and XIAP.'
reftext: T Kaufmann, et al. Cell Death Differ. 2012 Jan;19(1):42-50.
pmc_ranked_result_index: '19008'
pathway_score: 0.9423602
filename: cdd2011121f3.jpg
figtitle: Sensitisation of type 2 cancer cells towards DR-induced killing by synthetic
  IAP antagonists
year: '2012'
organisms: Homo sapiens
ndex: 5453264f-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3252833__cdd2011121f3.html
  '@type': Dataset
  description: Sensitisation of type 2 cancer cells towards DR-induced killing by
    synthetic IAP antagonists. (a) This image represents a type-2 cancer cell that,
    through overexpression of anti-apoptotic Bcl-2 proteins (e.g. Bcl-2 or Mcl-1)
    and/or XIAP, has become highly resistant towards FasL- or TRAIL-induced apoptosis.
    (b) Addition of an IAP-antagonistic small molecular Smac-mimetic, ideally an XIAP-selective
    inhibitor to minimise side effects, uncouples the DR-induced apoptotic pathway
    from its mandatory crosstalk to the mitochondrial apoptotic pathway, thereby sensitising
    the cancer cells towards FasL-, TRAIL- or TNF-induced killing. Combination therapy
    with additional standard chemotherapeutic drugs, or direct targeting of anti-apoptotic
    Bcl-2 proteins by BH3 mimetics, thereby triggering MOMP, might further sensitise
    the cancer cell to undergo apoptosis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PARP11
  - PARP16
  - PARP12
  - PARP6
  - CD9
  - PARP8
  - PARP3
  - CASP3
  - PARP14
  - TIPARP
  - PARP15
  - PARP2
  - BID
  - PARP1
  - CASP8
  - TNKS2
  - PARP9
  - DFFA
  - PARP4
  - XIAP
  - PARP10
  - TNKS
genes:
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: Ba2
  symbol: BA2
  source: hgnc_alias_symbol
  hgnc_symbol: CD9
  entrez: '928'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: CASP-3
  symbol: CASP3
  source: hgnc_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: BID
  symbol: BID
  source: hgnc_symbol
  hgnc_symbol: BID
  entrez: '637'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: (CASP-8
  symbol: CASP8
  source: hgnc_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: ICAD
  symbol: ICAD
  source: hgnc_alias_symbol
  hgnc_symbol: DFFA
  entrez: '1676'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: CASP-8
  symbol: Casp-8
  source: hgnc_alias_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
chemicals: []
diseases: []
---
